The grid below stacks naturally on smaller screens for clean reading on any device
CNNs Tal Yellin contributed to this report.
With files from Karen Bartko, Global News
Isabel Krug et al., Beyond Weight Loss: GLP1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes , 17 Nutrients 3735, 5 (2025), available at : (last visited Apr
Clinical trials such as STEP and SURMOUNT report outcomes over months, not weeks, and real-world results depend on adherence, dose, and personal metabolic factors that no program can fully predict
While each medication works independently, their combined use has generated interest among clinicians seeking to optimize weight loss outcomes in patients with obesity and related metabolic conditions